drugset / Trial / NCT03404063

Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI)

NCT03404063 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The main objective of the CIRCULATE project is to compare the clinical outcomes of CardioCell administration in treatment of ischemic damages of cardiovascular system with control group, who will be treated by the administration of placebo during the sham procedure.

Timeline

Start
2017-10-20
Primary completion
2020-07-02
Completion
2021-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject CardioCell Cell therapy 3e+07 cells Other

Indications